KDM1A and non-small cell lung carcinoma: Surprisingly, in contrast to treatment studies on acute myeloid leukemia and small‐cell lung cancer (Mohammad et al., 2015; Stazi et al., 2016), conventional MAO‐based LSD1 inhibitors neither affected the histone methylation status, nor influenced NSCLC cell growth.